Please assess the completion status of the following clinical trial:

Trial Title: Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 18-65 yr old adults with asthma, non-smoking for at least one year~* Healthy non-smoking adults, aged 18-65 without asthma~* Heavy subjects with BMI \> 30 kg/m2~* Subjects with normal weight (BMI between 20-25 kg/m2)~* Subject not taking anti-leukotriene therapy (Singulair, Accolate, Zyflo)~Exclusion Criteria:~* No chronic oral steroid use~* No recent history of infection~* No recent history of flare of lung disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Healthy non-asthmatic obese adults (Type: None): Healthy non-asthmatic obese adults
- Healthy non-asthmatic non-obese adults (Type: None): Healthy non-asthmatic non-obese adults
- Asthmatic obese adults (Type: None): Asthmatic obese adults
- Asthmatic non-obese adults (Type: None): Asthmatic non-obese adults

Based on this trial design, predict the completion outcome and termination type (if applicable).